| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 3,382 | 3,081 | 1,330 | | Cost of Revenue | 1,346 | 728 | 313 | | | Gross Profit | 2,036 | 2,353 | 1,017 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,766 | 1,597 | 208 | | Non Recurring |
-
|
-
|
-
| | Others | 900 | 698 | 154 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (630) | 58 | 655 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,214) | 135 | 17 | | Earnings Before Interest And Taxes | (2,844) | 193 | 672 | | Interest Expense | 89 | 102 | 223 | | Income Before Tax | (2,934) | 91 | 449 | | Income Tax Expense | (834) | 69 | 127 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,099) | 23 | 322 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,099) | 23 | 322 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,099) | $23 | $322 |
|
0.10% Nasdaq 
0.27%
Income Statement
